Amgen Inc.（AMGN）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · AMGN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$36.74B	$33.42B	$28.19B	$26.32B	$25.98B
Cost of Revenue	$10.73B	$12.86B	$8.41B	$6.41B	$6.45B
Gross Profit	$26.01B	$20.57B	$19.77B	$19.92B	$19.52B
Gross Margin %(computed)	70.80%	61.53%	70.15%	75.66%	75.16%
Operating Expenses
R&D Expenses	$6.97B	$5.96B	$4.78B	$4.43B	$6.32B
G&A Expenses	$0.00B	$6.11B	$0.00B	$4.57B	$4.53B
Total Operating Expenses	$15.34B	$13.31B	$11.84B	$10.35B	$11.89B
Operating Income	$10.68B	$7.26B	$7.90B	$9.57B	$7.64B
Operating Margin %(computed)	29.06%	21.71%	28.01%	36.34%	29.40%
Interest Income	$0.00B	$0.00B	$0.00B	$0.00B	$0.00B
Interest Expense	$2.75B	$3.15B	$2.88B	$1.41B	$1.20B
Income Before Tax	$8.98B	$4.61B	$7.86B	$7.35B	$6.70B
Income Tax Expense	$1.26B	$0.52B	$1.14B	$0.79B	$0.81B
Net Income	$7.71B	$4.09B	$6.72B	$6.55B	$5.89B
Net Margin %(computed)	20.99%	12.24%	23.83%	24.89%	22.68%
Per Share & EBITDA
EPS (Basic)	$14.33	$7.62	$12.56	$12.18	$10.34
Wtd Avg Shares	0.54B	0.54B	0.54B	0.54B	0.57B
EBITDA	$15.84B	$13.36B	$14.80B	$12.17B	$11.30B
EBITDA Margin %(computed)	43.12%	39.96%	52.50%	46.23%	43.48%